Results 141 to 150 of about 104,696 (276)

Scale and rate heterogeneity in the EQ-5D-5L valuation

Health and Quality of Life Outcomes
Abstract Objectives To estimate values on a quality-adjusted life year (QALY) scale using individual preference evidence, choice analyses typically include ancillary parameters, such as scale factors and discount rates. These parameters potentially differ among respondents.
Maksat Jumamyradov, Benjamin M. Craig, Michał Jakubczyk   +2 more
openaire   +3 more sources

Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L value sets

, 2017
Objectives: Quality-adjusted life-years are the common outcome measure in contemporary economic evaluations in health care. Due to the limitations of the sensitivity of the EQ-5D-3L in specific disease conditions, the EuroQoL group has developed a new
Scuffham, Paul, Kularatna, Sanjeewa, Byrnes, J, Paul A. Scuffham, Kularatna, S, Scuffham, PA, Byrnes, Josh, Scuffham, Paul A., Sanjeewa Kularatna, Chen, Gang, Josh Byrnes, Gang Chen, Byrnes, Joshua, Chen, G   +13 more
core   +1 more source

Synthesis of Single‐Crystalline Ni‐Rich Cathodes for Lithium‐Ion Batteries With Superior High‐Voltage Stability by Mo/Nb Dual Doping

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
A novel synthesis method of single‐crystalline LiNi0.8Co0.15Al0.05O2 (NCA) is introduced, involving the stripping of grain boundaries from polycrystalline NCA (PC‐NCA) during Mo/Nb co‐doping. Mo doping near the grain surface significantly reduces parasitic interface reactions and inhibits the excessive growth of CEI films, while Nb doping within the ...
Guomeng Xie, Ziqin Xu, Delai Qian, Ruiwu Li, Qingsong Hua, Shun Lu, Haitao Fang   +6 more
wiley   +1 more source

Comparison of EQ-5D-5L health state utilities using four country-specific tariffs on a breast cancer patient sample in mainland China

, 2017
Liu Liu,1,2 Shunping Li,1,2 Min Wang,3 Gang Chen4 1School of Health Care Management, Shandong University, Jinan, China; 2Key Laboratory of Health Economics and Policy Research, NHFPC (Shandong University), Jinan, China; 3Qingdao Municipal Hospital ...
Wang M, Liu L, Chen G, Li SP
core  

Additional file 2: of Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys

, 2018
EQ-5D-5L comparison between 5th and 6th waves to assess effect of administering it after EQ-5D-3L.
MĂłnica Ávila (3585170), Carlos G. Forero (2793622), Juan CabasĂŠs (5639924), Ricard Tresserras (2064124), Antonia Medina-Bustos (5117330), Montse Ferrer (436419), Marc MartĂ­-Pastor (5639906), Luis Rajmil (5609885), Yolanda Pardo (3585161), Angels Pont (3585158), Gemma Vilagut (418578), Olatz Garin (178963), Oriol Garcia-Codina (5117333), Jordi Alonso (178939)   +13 more
core   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Epilepsy in emerging adulthood: Clinical, psychosocial, and surgical challenges

Epilepsia, EarlyView.
Abstract Objective Emerging adulthood (EAs; ages 19–29 years) is a unique developmental stage marked by major psychological, social, and occupational transitions. We sought to characterize the clinical, psychosocial, and surgical features of epilepsy in emerging adulthood, considering both current age and age at epilepsy onset.
Graham A. McLeod, Colin B. Josephson, Samuel Wiebe, The Calgary Comprehensive Epilepsy Program Collaborators, Felippe Borlot, Guillermo Delgado‐García, Paolo Federico, Nathalie Jette, Karl Martin Klein, William Murphy, Neelan Pillay, Andrea Salmon, Shaily Singh, The Epilepsy Surgery Satisfaction Questionnaire Study Group, Mark J. Atkinson, Walter J. Hader, Mark R. Keezer, Oluwaseyi A. Lawal, Sophia Macrodimitris, Kristina Malmgren, Dang K. Nguyen, Scott B. Patten, Tolulope T. Sajobi, Ruby Sharma, Yves Starreveld, José Tellez‐Zenteno, Sandra Wahby   +26 more
wiley   +1 more source

An Evaluation of Generic and Disease‐Specific Patient‐Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health‐Related Quality of Life in a European Population

JEADV Clinical Practice
Background Hair loss due to alopecia areata (AA) can negatively impact patients’ health‐related quality of life (HRQoL). Patient‐reported outcome measures (PROMs) like the EQ‐5D‐5L and the Alopecia Areata Patient Priority Outcomes (AAPPO) represent ...
K. A. Hanson, S. Marwaha, S. K. Kurosky, M. Harries, P. Anderson, J. Piercy, V. Basey, J. Austin, E. H. Law   +8 more
doaj   +1 more source

Real world testing and cost‐effectiveness analysis of subcutaneous EEG (REAL‐ASE): Protocol for a prospective multicentre interventional trial

Epilepsia Open, EarlyView.
Abstract Objective Epilepsy is a common condition associated with significant morbidity, mortality, and costs. Poor documentation of seizures is a major challenge in epilepsy care. Objective seizure counting with mobile devices may mitigate this challenge and improve patient management.
Matthew McWilliam, Pedro F. Viana, Eren Dursun, Joe Davies, Joel S. Winston, Jessica Agren, Harutomo Hasegawa, Jonas Duun‐Henriksen, Mark P. Richardson   +8 more
wiley   +1 more source

Silencing SGO2 by Oxamic Acid Dissociates Glycolysis and BRCA1‐Mediated DNA Repair to Improve the Chemosensitivity of Lung Adenocarcinoma

Exploration, EarlyView.
SGO2 interacts with BRCA1 to inhibit BRCA1 ubiquitination and degradation, thereby promoting BRCA1‐induced DNA damage repair signaling and reducing the chemo sensitivity of LUADa. OA targets glycolysis to disrupt H3K18la‐ and H3K27ac‐mediated chromatin accessibility, repressing SGO2 transcription and subsequently alleviating SGO2‐mediated cancer ...
Xian Lin, Zhidan Hua, Chen Liu, Minxia Yang, Beilei Zhang, Xiaofeng Zhu, Xiao Chen   +6 more
wiley   +1 more source